Daewoong Co., Ltd - 21 Jul 2023 Form 3 Insider Report for AEON Biopharma, Inc. (AEON)

Role
10%+ Owner
Signature
Daewoong Co., Ltd., By: /s/ Kyu Sung Lim, Authorized Signatory
Issuer symbol
AEON
Transactions as of
21 Jul 2023
Net transactions value
$0
Form type
3
Filing time
28 Jul 2023, 07:54:31 UTC
Next filing
26 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AEON Common Stock, $0.0001 par value per share 4,177,604 21 Jul 2023 Direct
holding AEON Common Stock, $0.0001 par value per share 2,400,000 21 Jul 2023 Indirect Beneficial Ownership in the 2,400,000 owned by Daewoong Pharmaceutical Co., Ltd F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Daewoong Co., Ltd., a company organized under the laws of the Republic of Korea, owns 51% of the outstanding shares of Daewoong Pharmaceutical Co., Ltd., a company organized under the laws of the Republic of Korea; Daewoong Co., Ltd. has voting power and dispositive power over Daewoong Pharmaceutical Co., Ltd. and therefore may be deemed to indirectly own such shares.